Product Name: BPC-157
Type: Tissue Recovery Research Peptide

Research Focus:

BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide derived from a gastric protein sequence studied for tissue-healing and cytoprotective properties[1][2]. Preclinical models demonstrate accelerated wound repair and anti-inflammatory activity[3], though human clinical data remain limited to early-phase safety trials and small case reports[4][5]. This educational protocol presents a once-daily subcutaneousapproach using a practical dilution for clear insulin-syringe measurements.

Research Interest:

• Tissue repair and regeneration studies

• Muscle and connective tissue recovery models

• Cellular protection pathway research

• Inflammatory response modulation studies

Scientific Interest:

• Angiogenesis and tissue repair signaling

• Cellular resilience mechanisms

• Structural tissue recovery pathways

Reconstitution:

• Reconstitute: Add 3.0 mLbacteriostatic water → 3.33 mg/mLconcentration.

• Typical daily range: 200–600 mcgonce daily (gradual titration).

• Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.3 mcg on a U-100 insulin syringe.

• Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.

Cycle:

Standard / Gradual Approach (3 mL = ~3.33 mg/mL)

Frequency: Inject once dailysubcutaneously. This schedule uses the largest practical dilution (3.0 mL) to keep per-injection units well above 5 for better accuracy. Dosing is extrapolated from preclinical models[1][6]; human clinical validation remains limited.

Reconstitution Steps

1. Draw 3.0 mL bacteriostatic water with a sterile syringe.

2. Inject slowly down the vial wall; avoid foaming.

3. Gently swirl/roll until dissolved (do not shake).

4. Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

IMPORTANT NOTICE:

This product is intended strictly for laboratory research. It is not intended to diagnose, treat, cure, or prevent any disease.